A Conversation on the Role of Rapid-Acting Therapies in the Management of Major Depressive Disorder

home / primary-view / a-conversation-on-the-role-of-rapid-acting-therapies-in-the-management-of-major-depressive

Experts in psychiatry focus on the role of rapid-acting therapies, specifically GABAA receptor modulators in the management of major depressive disorder (MDD). The discussion explores their mechanism of action, their clinical utility as an effective treatment option, and the ongoing research efforts within this area.

© 2024 MJH Life Sciences

All rights reserved.